Literature DB >> 18467594

Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.

Stéphanie Cébe-Suarez1, Felix S Grünewald, Rolf Jaussi, Xiujuan Li, Lena Claesson-Welsh, Dorothe Spillmann, Andrew A Mercer, Andrea E Prota, Kurt Ballmer-Hofer.   

Abstract

Vascular endothelial growth factors (VEGFs) interact with the receptor tyrosine kinases (RTKs) VEGFR-1, -2, and -3; neuropilins (NRPs); and heparan sulfate (HS) proteoglycans. VEGF RTKs signal to downstream targets upon ligand-induced tyrosine phosphorylation, while NRPs and HS act as coreceptors that lack enzymatic activity yet modulate signal output by VEGF RTKs. VEGFs exist in various isoforms with distinct receptor specificity and biological activity. Here, a series of mammalian VEGF-A splice variants and orf virus VEGF-Es, as well as chimeric and mutant VEGF variants, were characterized to determine the motifs required for binding to NRP-1 in the absence (VEGF-E) or presence (VEGF-A(165)) of an HS-binding sequence. We identified the carboxyterminal peptides RPPR and DKPRR as the NRP-1 binding motifs of VEGF-E and VEGF-A, respectively. RPPR had significantly higher affinity for NRP-1 than DKPRR. VEGFs containing an RPPR motif promoted HS-independent coreceptor complex assembly between VEGFR-2 and NRP-1, independent of whether these receptors were expressed on the same or separate cells grown in cocultures. Functional studies showed that stable coreceptor assembly by VEGF correlated with its ability to promote vessel formation in an embryoid body angiogenesis assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467594     DOI: 10.1096/fj.08-107219

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

Review 1.  VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance.

Authors:  Kevin M Sargent; Debra T Clopton; Ningxia Lu; William E Pohlmeier; Andrea S Cupp
Journal:  Cell Tissue Res       Date:  2015-11-09       Impact factor: 5.249

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Authors:  Prakash Vempati; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cytokine Growth Factor Rev       Date:  2013-11-27       Impact factor: 7.638

4.  Structural determinants of growth factor binding and specificity by VEGF receptor 2.

Authors:  Veli-Matti Leppänen; Andrea E Prota; Michael Jeltsch; Andrey Anisimov; Nisse Kalkkinen; Tomas Strandin; Hilkka Lankinen; Adrian Goldman; Kurt Ballmer-Hofer; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-09       Impact factor: 11.205

5.  Recombinant human VEGF165b inhibits experimental choroidal neovascularization.

Authors:  Jing Hua; Christine Spee; Satoru Kase; Emma S Rennel; Anette L Magnussen; Yan Qiu; Alex Varey; Sandeep Dhayade; Amanda J Churchill; Steven J Harper; David O Bates; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

6.  Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.

Authors:  Harukiyo Kawamura; Xiujuan Li; Katsutoshi Goishi; Laurens A van Meeteren; Lars Jakobsson; Stéphanie Cébe-Suarez; Akio Shimizu; Dan Edholm; Kurt Ballmer-Hofer; Lena Kjellén; Michael Klagsbrun; Lena Claesson-Welsh
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

7.  VEGF in the lung: a role for novel isoforms.

Authors:  Julia Varet; Samantha K Douglas; Laura Gilmartin; Andrew R L Medford; David O Bates; Steven J Harper; Ann B Millar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-12       Impact factor: 5.464

Review 8.  The role of VEGF 165b in pathophysiology.

Authors:  Maria Peiris-Pagès
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

9.  HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Authors:  Sophie Lambert; Manuella Bouttier; Roger Vassy; Michel Seigneuret; Cari Petrow-Sadowski; Sébastien Janvier; Nikolaus Heveker; Francis W Ruscetti; Gérard Perret; Kathryn S Jones; Claudine Pique
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

10.  VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.

Authors:  E S Rennel; A H R Varey; A J Churchill; E R Wheatley; L Stewart; S Mather; D O Bates; S J Harper
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.